- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03785912
SelFIT: Internet-based Treatment for Adjustment Problems After an Accident (SelFIT)
December 13, 2021 updated by: University of Bern
Randomized Controlled Trial (RCT) to Evaluate the Efficacy and Cost-effectiveness of an Internet-based Self-help Program for People With Adjustment Problems After an Accident
In this study, people who suffer from adjustment problems after having experienced an accident will be randomized to one of two study groups.
The first group receives access to the internet-based self-help intervention immediately.
The second group is a waiting control group that receives access to the program 12 weeks later.
In both conditions additional care or treatment is allowed.
The aim of the study is to investigate the efficacy and cost-effectiveness of an internet-based self-help intervention for people with adjustment problems after an accident compared to a waiting list.
There are 6 assessments, which all take place online: baseline, two between-measurements (after 4 and 8 weeks), post assessment (after 12 weeks) and two follow-up assessments (after 3 and 6 months).
All participants from both groups are asked to fill out all assessments.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3012
- Universität Bern
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: All participants must...
- be at least 18 years old
- give a declaration of consent to participate in the study
- have access to the Internet
- understand and master the German language to the degree that they understand the contents and instructions of the study
- exceed the cut-off value for at least a mild psychological burden on the depression-anxiety stress scale (DASS- 21)
- be able to specify an emergency address in the event of an acute crisis
- have experienced and can specify an accident during a period of two weeks to two years prior to participation in the current study that lead to the conditions described above.
Exclusion Criteria: Excluded are persons who...
- show severe depressive symptoms (Beck depression inventory [BDI-II] > 29)
- show suicidal tendencies (BDI-II Suicide item > 1)
- have a known diagnosis of psychotic or bipolar disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Internet-based self-help
The self-help program consists of eight text- and video-based modules.
All participants in this group receive immediate access to the self-help program.
The program's self-management approach does not provide for regular support from a specialist.
However, participants can contact the study team if they need or want additional help.
|
Eight cognitive-behavioral, mindfulness and acceptance commitment based modules focusing on different aspects of adjustment problems after having an accident.
|
No Intervention: Waiting control group
Access to internet-based intervention after 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
DASS-21: Depression, Angst, Stress-Skala (Lovibond & Lovibond, 1995)
Time Frame: 7 minutes
|
21-item questionnaire assessing depression, anxiety and stress symptoms
|
7 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BDI-II:Beck Depression Inventory (Beck et al., 1996; Margraf & Ehlers, 1998)
Time Frame: 5-10 minutes
|
21-item questionnaire assessing depressive symptoms
|
5-10 minutes
|
ADNM-20: Adjustment Disorder - New Module 20 (Lorenz et al., 2016)
Time Frame: 6 minutes
|
20-item questionnaire assessing adjustment disorder symptoms and severity
|
6 minutes
|
SF-12: Short Form Health Survey (Ware et al., 1996)
Time Frame: 5 minutes
|
12-item questionnaire assessing various aspects of well-being
|
5 minutes
|
LOT-R: Revised Life Orientation Test (Herzberg et al., 2006)
Time Frame: 3 minutes
|
10-item questionnaire assessing optimism and pessimism
|
3 minutes
|
BVI: Berner Verbitterungsinventar (Znoj, 2008)
Time Frame: 3 minutes
|
18-item questionnaire assessing embitterment
|
3 minutes
|
FAB: Fragebogen Arbeit und Wohlbefinden (Abegglen et al., 2017)
Time Frame: 5 minutes
|
24-item questionnaire assessing different aspects of work- and health-related topics
|
5 minutes
|
TIC-P: Treatment inventory of Costs in Psychiatric Patients (Bouwmans et al., 2013)
Time Frame: 20 minutes
|
58-item questionnaire assessing costs related to an accident
|
20 minutes
|
ZUF-8: Zufriedenheitsfragebogen (Attkisson & Zwick, 1982)
Time Frame: 2 minutes
|
8-item questionnaire assessing content with an online-program
|
2 minutes
|
SUS: System Usability Scale (Brooke, 1996)
Time Frame: 3 minutes
|
10-item questionnaire assessing usability of an online-program
|
3 minutes
|
SWE: Skala zur Allgemeinen Selbstwirksamkeit (Jerusalem & Schwarzer, 2003)
Time Frame: 3 minutes
|
10-item questionnaire assessing general self-efficacy
|
3 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Hansjörg Znoj, Prof. Dr., University of Bern
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 18, 2019
Primary Completion (Actual)
November 28, 2021
Study Completion (Actual)
November 28, 2021
Study Registration Dates
First Submitted
December 20, 2018
First Submitted That Met QC Criteria
December 20, 2018
First Posted (Actual)
December 24, 2018
Study Record Updates
Last Update Posted (Actual)
December 14, 2021
Last Update Submitted That Met QC Criteria
December 13, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-01059
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorder
-
Vincent AgyapongNova Scotia Health Authority; Dalhousie UniversityRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Mental Health Wellness 1Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Brigham and Women's HospitalRecruitingDepression | Mood Disorders | Depressive Disorder, Major | Psychiatric Disorder | Mental DisorderUnited States
-
Queen's UniversityCompleted
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
Brigham and Women's HospitalNot yet recruitingDepression | PTSD | Mood Disorders | Anxiety Disorders | OCD | Major Depressive Disorder | Psychiatric Disorder | Mental Disorder
-
H. Lundbeck A/SCompletedMajor Depression DisorderGermany, United States, Estonia, Finland, Poland
-
GlaxoSmithKlineCompleted
Clinical Trials on Internet-based self-help
-
University of BernCompletedPsychological Distress | Coronavirus | Adjustment, PsychologicalSwitzerland
-
University of BernCompletedProlonged Grief SymptomsSwitzerland
-
University of BernUniversity of ZurichCompleted
-
University of BernCompletedSelf-criticismSwitzerland
-
University of BernUniversity Hospital Inselspital, BerneTerminated
-
Helse Møre og Romsdal HFCompleted
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedCigarette SmokingUnited States
-
Uppsala UniversityCompletedDepression | Cancer | AnxietySweden
-
University of BernUniversitätsklinikum Hamburg-EppendorfCompletedSchizophrenia | Hallucinations | Persecutory DelusionGermany, Switzerland
-
University of EdinburghNHS TaysideCompletedAnorexia Nervosa | Bulimia Nervosa | Binge Eating Disorder | Other Specified Feeding or Eating DisorderUnited Kingdom